BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23409180)

  • 1. CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.
    Chen S; Song X; Chen Z; Li X; Li M; Liu H; Li J
    PLoS One; 2013; 8(2):e56380. PubMed ID: 23409180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of CD133 expression in colorectal cancer: a meta-analysis.
    Wang K; Xu J; Zhang J; Huang J
    BMC Cancer; 2012 Dec; 12():573. PubMed ID: 23216926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies.
    Huang R; Mo D; Wu J; Ai H; Lu Y
    Medicine (Baltimore); 2018 Jun; 97(23):e10446. PubMed ID: 29879012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.
    Kojima M; Ishii G; Atsumi N; Fujii S; Saito N; Ochiai A
    Cancer Sci; 2008 Aug; 99(8):1578-83. PubMed ID: 18754869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review.
    Qu H; Li R; Liu Z; Zhang J; Luo R
    Int J Clin Exp Pathol; 2013; 6(11):2644-50. PubMed ID: 24228135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 Expression in Lymph Node Metastases Is Associated with Tumor Aggressiveness During Lymph Node Metastasis in Colorectal Cancer.
    Kazama S; Kishikawa J; Yasuda K; Otani K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Yamaguchi H; Ishihara S; Sunami E; Watanabe T
    Anticancer Res; 2015 Dec; 35(12):6599-605. PubMed ID: 26637875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients.
    Takahashi S; Kamiyama T; Tomaru U; Ishizu A; Shida T; Osaka M; Sato Y; Saji Y; Ozaki M; Todo S
    Oncol Rep; 2010 Nov; 24(5):1201-12. PubMed ID: 20878111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
    Zhong C; Wu JD; Fang MM; Pu LY
    Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review.
    Wen L; Chen XZ; Yang K; Chen ZX; Zhang B; Chen JP; Zhou ZG; Mo XM; Hu JK
    PLoS One; 2013; 8(3):e59154. PubMed ID: 23533603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy.
    Mia-Jan K; Jung SY; Kim IY; Oh SS; Choi E; Chang SJ; Kang TY; Cho MY
    BMC Cancer; 2013 Mar; 13():166. PubMed ID: 23537343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
    Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
    Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis.
    Yang K; Chen XZ; Zhang B; Yang C; Chen HN; Chen ZX; Zhou ZG; Chen JP; Hu JK
    Int J Biol Markers; 2011; 26(3):173-80. PubMed ID: 21786247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
    Kemper K; Versloot M; Cameron K; Colak S; de Sousa e Melo F; de Jong JH; Bleackley J; Vermeulen L; Versteeg R; Koster J; Medema JP
    Clin Cancer Res; 2012 Jun; 18(11):3132-41. PubMed ID: 22496204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.